Filing Flows › Lemaitre Vascular (LMAT) › Q2 2025
Lemaitre Vascular (LMAT) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 6, 2025
Lemaitre Vascular (LMAT) reported revenue of $64.2M for the second quarter 2025 (Q2 2025), +15% from a year earlier and +7% from the quarter before. Operating margin was 25.1%, net earnings $13.8M (21.5% of revenue).
Lemaitre Vascular, Q2 2025: revenue $64.2M (+15% year over year), operating margin 25.1%, net earnings $13.8M, operating cash flow $20.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $64.2M | +7% | +15% |
| Gross profit | $45.0M | +9% | +17% |
| Operating profit | $16.1M | +28% | +12% |
| Net earnings | $13.8M | +25% | +17% |
| Operating cash flow | $20.3M | +124% | +111% |
| Free cash flow | $18.9M | +148% | +145% |
What changed
Revenue was $64.2M in Q2 2025, up 15% year over year and up 7% from the previous quarter.
Gross margin was 70.0%, up 1.1 points from a year earlier. Operating profit was $16.1M, a 25.1% margin (down 0.6 points year over year). Of the extra revenue versus a year earlier, 21% reached operating profit, below the 26% margin then. Operating expenses grew 20% against revenue growth of 15%. The fastest-growing cost line was Sales & marketing (+36%). Net earnings were $13.8M, up 17% year over year. The effective tax rate was 23.7%.
Operating cash flow was $20.3M (up 111% year over year), 147% of net earnings. Non-cash charges added back $2.6M of depreciation and amortization and $1.9M of share-based compensation. Working capital and other items added $1.9M. Capital expenditures of $1.3M left free cash flow of $18.9M.
Questions
What was Lemaitre Vascular's revenue in the second quarter 2025?
Lemaitre Vascular (LMAT) reported revenue of $64.2M for the second quarter 2025 (Q2 2025), +15% from a year earlier and +7% from the quarter before.
Was Lemaitre Vascular profitable in the second quarter 2025?
Operating profit was $16.1M (25.1% of revenue) and net earnings $13.8M.
Source: Lemaitre Vascular 10-Q on SEC EDGAR.